US EditionBlood Community Comments to FDA on Reducing the Risk of Transmission of Hepatitis B Virus by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)
Summary by America's Blood Centers
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Blood Community Comments to FDA on Reducing the Risk of Transmission of Hepatitis B Virus by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)
This joint comment from the Association for the Advancement of Blood and Biotherapies (AABB), America’s Blood Centers (ABC), and the American Red Cross (ARC) to the U.S. Food and Drug Administration (FDA), offers feedback on the draft guidance concerning the mitigation of Hepatitis B Virus (HBV) transmission through human cells, tissues, and cellular and tissue-based products (HCT/Ps). In the submission, the organizations express their support f…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
